RareCyte
RareCyte develops spatial proteomics and liquid biopsy platforms for researchers, biopharma companies and clinical research teams. Its Orion platform profiles multiple markers in tissue, while CyteFinder detects rare cells, including circulating tumor cells, in blood samples to support biomarker development and precision biology.
Facts
- HQ
- Seattle
- Sectors
- Biotechnology Research
- Founded
- 2009
- Employees
- 62
- Members see funding amounts. .
Is this your organization? Claim it
Recent coverage
Front-page news, podcasts and videos about RareCyte
RareCyte raises $24M to commercialize Orion 21-channel high-speed cell imaging platform
Seattle startup RareCyte raised $24 million to commercialize and expand its Orion high-speed, 21-channel fluorescent cell imaging and analysis platform and other automated biopsy products for researchers and biopharma.
People
-
Ronald Seubert Founder
-
Joe Victor Executive, CEO
Online
Questions about RareCyte
What is RareCyte?
rarecyte.com
Who are the people behind RareCyte?
Seattle Flow lists Ronald Seubert (Founder) and Joe Victor (Executive, CEO) at RareCyte.
Who invested in RareCyte, and how much has it raised?
Members of Seattle Flow see RareCyte's funding rounds, amounts and investors on its Funding tab. Joining is free.
Where is RareCyte based?
RareCyte is headquartered in Seattle.
When was RareCyte founded?
RareCyte was founded in 2009.
How many people work at RareCyte?
RareCyte has 62 employees.